{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-000169","form_type":"8-K","ticker":"CDIO","cik":"0001870144","company_name":"Cardio Diagnostics Holdings, Inc.","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.174750+00:00","generated_at":"2026-06-06T11:35:56.646954+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cardio Diagnostics enters $17M at-the-market equity offering with Craig-Hallum","bullets":["Up to $17M in common stock may be sold via Craig-Hallum as sales agent under an ATM offering.","Craig-Hallum will receive 2.5% commission on gross proceeds; legal fee reimbursement up to $55,000.","Proceeds to be used for general corporate purposes, including working capital and capex.","Registration statement on Form S-3 declared effective by SEC on February 1, 2024.","Sales may be made on Nasdaq Capital Market through ordinary brokers' transactions or negotiated deals."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-000169","json":"https://secwatch.observer/filing/0001079973-24-000169.json","markdown":"https://secwatch.observer/filing/0001079973-24-000169.md","text":"https://secwatch.observer/filing/0001079973-24-000169.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870144/000107997324000169/0001079973-24-000169-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870144/000107997324000169/cdio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T11:35:56.646954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3020345eb33a569675cdd225f67c168924a2f2ba","claim":"Cardio Diagnostics Holdings, Inc. entered into Sales Agreement with Craig-Hallum Capital Group LLC valued at up to an aggregate of $17 million (effective 2024-01-26).","evidence_excerpt":"On January 26, 2024, Cardio Diagnostics Holdings, Inc. (the “Company”) entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”). Pursuant to the Sales Agreement, the Company may sell, at its option, up to an aggregate of $17 million in shares of its common stock through Craig-Hallum, as sales agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870144/000107997324000169/0001079973-24-000169-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Craig-Hallum Capital Group LLC"},{"label":"Value","value":"up to an aggregate of $17 million"},{"label":"Effective","value":"2024-01-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}